Novalithera Sciences is an AI-driven biotherapeutic company dedicated to transforming the way novel treatments are discovered and developed. Our multidisciplinary team unites computational scientists, bioinformaticians, and drug discovery experts who collaborate at the intersection of machine learning and molecular biology.
We operate proprietary training and inference clusters that process vast biological datasets — from genomic sequences to protein structures — enabling predictive modeling at enterprise scale. Every engagement is custom-tailored: we work closely with each enterprise partner to design computational pipelines that address their specific research objectives and therapeutic programs.
With offices across multiple continents, we serve a growing network of pharmaceutical companies, biotechnology firms, healthcare organizations, and academic research institutes. Our global presence ensures close collaboration with partners while maintaining rigorous data security and operational standards.
